Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Impressive fireside presentation . Still years away from an approved drug but likely to seek accelerated path .
Rare diseases only require one pivotal trial ...and their trial don't require biopsies...so easier to enroll .
2 yr safety data looks good
Potential multi billion $ markets
Kiwi
Will sell some teens at 50$, mega profits $$$$$$
Complete beast, 50 may be sooner than expected
Chart still in an upward spiral $$$$$
Moving up again, rna is a winner folks
Loaded 10-10-50’s, sold half here… $$$$$, it has been on a tear my friends, don’t get greedy lol
Called it, 20’s are in, 23.80 tough break, we’l see
6.25-7 buys are making wealth! Beautiful chart moving forward $$$$$
It’l b 20+ again, soon
Any idea why this popped yesterday on heavy volume,any rumors/talk? This is a keeper for sure, wondering why it jumped yesterday.
This will be 15 in a matter of time, something huge brewing an bms knows it, they are in on it now. Buy now an hold. Loading zone imo $$$$$$
6.85 WTF MEANWHILE HNRA GOING UP^UP
AND RDHL HALTED UP
GRRRRRRRRR
Boom, ya just never know with bio’s! $$$$$$$$$,
Insiders are buying something is coming, 20+ again, we shall see
8.90’s was the floor. Lets see this back to 20, wwweeeeee $$$$$
Wow, haven’t been following this, under 11.00, this was recently 25.00 stock, shorting should be illegal, poor souls who entered this in the 20’s have been lefted!
With some superb news we see 30’s very fast here, in this for the long haul, have patience
Looks trashy. I will short this dead trash all day tomorrow. Watch out. This is trash trash trash. Haahahahhahaha ooooooooooooiooooof
Back in long, reversal will happen
Buy an hold, wow opportunity of wealth again here
Sold the high 22’s, this may get shorted back to the 14/15’s on the long wait for their sciences
Great interim trial news... so shorting RNA is a time bomb... Lifting hold on new candidates in the current trial will add $10 to stock without squeeze...likely a double SP on the news with the aid of with flippers like you chasing to cover... make my day!
This stock right now is a flippers dream, wild swings, getting in an out makes u money.
Long way to go to get anywhere clise to moderna my friend, a long long way. 5 yrs minimum if this science even gets to ph 3
Where have you been collecting your bread crumbs, this company has over 400 million dollars in the coffers, that is why the stock is behaving like it is. The next Moderna.
Stock offering/dilution, let it drop, shorting this is money!, at least for now. We’l buy long after all the shares settle down. Plenty shares to short now. Money made easy here
The next Moderna in the making. Boom
$RNA DD Notes ~ http://www.ddnotesmaker.com/RNA
bullish
$RNA recent news/filings
## source: finance.yahoo.com
Fri, 17 Oct 2014 22:03:19 GMT ~ Nasdaq stocks posting largest percentage increases
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220237991--finance.html
*********************************************************
Wed, 15 Oct 2014 12:19:06 GMT ~ Prosensa (RNA) Shares March Higher, Can It Continue?
read full: http://finance.yahoo.com/news/prosensa-rna-shares-march-higher-121906240.html
*********************************************************
Tue, 14 Oct 2014 10:31:16 GMT ~ Prosensa Holding N.V. (RNA) in Focus: Stock up 8.5%
read full: http://finance.yahoo.com/news/prosensa-holding-n-v-rna-103116677.html
*********************************************************
Mon, 13 Oct 2014 20:30:02 GMT ~ Prosensa Starts Rolling NDA Submission for Drisapersen
read full: http://finance.yahoo.com/news/prosensa-starts-rolling-nda-submission-203002061.html
*********************************************************
Mon, 13 Oct 2014 16:29:00 GMT ~ Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study
read full: http://www.thestreet.com/story/12911313/1/sarepta-drug-could-benefit-from-duchenne-muscular-dystrophy-patient-study.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
$RNA charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$RNA company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/RNA/company-info
Ticker: $RNA
OTC Market Place: Not Available
CIK code: not found
Company name: Prosensa Holding N.V.
Incorporated In:
Business Description:
$RNA share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$RNA extra dd links
Company name: Prosensa Holding N.V.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RNA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RNA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RNA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RNA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RNA+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/news - http://finance.yahoo.com/q/h?s=RNA+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RNA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RNA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RNA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RNA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RNA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RNA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RNA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Prosensa+Holding+N.V.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Prosensa+Holding+N.V.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Prosensa+Holding+N.V.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RNA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RNA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RNA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RNA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RNA/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RNA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RNA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RNA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RNA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RNA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RNA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RNA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RNA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RNA+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RNA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RNA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RNA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RNA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RNA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RNA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RNA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RNA/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RNA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RNA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RNA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RNA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RNA
$RNA DD Notes ~ http://www.ddnotesmaker.com/RNA
$RNA Roth Capital Sees 93% Upside In Prosensa But Financial Overhang Still Exist http://www.smarteranalyst.com/2014/09/19/roth-capital-sees-93-upside-prosensa-financial-overhang-still-exist/
$RNA Roth Capital Upgrades Prosena To Buy, Sees %175 Upside For The Stock http://www.smarteranalyst.com/2014/07/29/roth-capital-upgrades-prosena-to-buy-sees-5-upside-for-the-stock/
Followers
|
7
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
641
|
Created
|
09/06/13
|
Type
|
Free
|
Moderators |
Prosensa is a biopharmaceutical company focused on the discovery, development and commercialization of RNA modulating therapeutics. The company targets genetic disorders with a large unmet medical need, with a primary focus on neuromuscular and neurodegenerative disorders such as Duchenne Muscular Dystrophy (DMD), Myotonic Dystrophy (DM1) andHuntington's Disease (HD).
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |